Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03953461
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NSK | N-SUCCINYL LYSINE | A | 2P8B | 0.73 |  |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.73 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.75 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.73 | |
| REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.73 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.74 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.72 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.72 | |
DTB | 6-(5-METHYL-2-OXO-IMIDAZOLIDIN- 4-YL)-HEXANOIC ACID | A,B | 1R30 | 0.7 | |
| DTB | 6-(5-METHYL-2-OXO-IMIDAZOLIDIN- 4-YL)-HEXANOIC ACID | A | 1DAM | 0.7 | |
| DTB | 6-(5-METHYL-2-OXO-IMIDAZOLIDIN- 4-YL)-HEXANOIC ACID | A,B,C,D | 3FPA | 0.7 | |
DAA | 8-AMINO-7-CARBOXYAMINO-NONANOIC ACID WITH ALUMINUM FLUORIDE | A | 1BS1 | 0.75 | |
U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | B | 1GNO | 0.7 | |
| U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | B | 1A9M | 0.7 | |
| U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1AXA | 0.7 | |
| U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1GNM | 0.7 | |
| U0E | N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL- 2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]- CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE | A | 1GNN | 0.7 | |
BUJ | (3R)-3-(hexadecanoylamino)-4-(trimethylammonio)butanoate | A,B | 2RCU | 0.72 | |
IKT | 3-(1-AMINOETHYL)NONANEDIOIC ACID | A | 1DAE | 0.73 | |
ITL | (3alpha,5alpha,8alpha)-3-[(N,N- bis{2-[bis(carboxymethyl)amino]ethyl}- L-gamma-glutamyl)amino]cholan-24- oic acid | A | 2K62 | 0.72 | |
NC7 | 7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID | A | 1ZD5 | 0.7 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.72 | |
DPU | MIXED CARBAMIC PHOSPHORIC ACID ANHYDRIDE OF 7,8- DIAMINONONANIC ACID | A | 1DAK | 0.71 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAG | 0.77 | |
| DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAF | 0.77 | |
| DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A,B,C,D | 3FMF | 0.77 | |
| DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAI | 0.77 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.71 | |
UZ9 | (2S)-2-AMINO-6-({(4R)-4-[(10R,13S)- 10,13-DIMETHYL-3-OXOHEXADECAHYDRO- 1H-CYCLOPENTA[A]PHENANTHREN-17- YL]PENTANOYL}AMINO)HEXANOIC ACID | A,B | 1UZ9 | 0.75 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.74 | |